Search Symbol

Most Active Stocks

NIACL

HDFCBANK

DMART

VBL

TATAMOTORS

ICICIBANK

JAYNECOIND

RELIANCE

BHARTIARTL

EBGNG

AXISBANK

TCS

INFY

WAAREEENER

AMBER

KOTAKBANK

M&M

SBIN

INDIGO

Zydus Lifesciences Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers active pharmaceutical ingredients, finished dosage formulations, generics, specialty, biosimilars, vaccines, novel products, consumer wellness and animal health products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands. The company also provides a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses, as well as in the therapeutic areas of pain management, neurology, metabolic disorder, and neurology. In addition, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.

Key Information

Market Cap

991393873920

Current Price

956.75

52 Week Range

795.0 - 1324.3

Previous Close

970.0

Open

970.0

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

Zydus Corporate Park, Scheme No. 63 Survey No. 536 Khoraj (Gandhinagar),Near Vaishnodevi Ci, Ahmedabad, 382481, India

Phone

+91-79480-40000

Fax

+91-79268-68337

Website

https://zyduslife.com

Financials

Day Low

951.55

Day High

972.85

Dividend Yield

1.13

PE Ratio

21.256388

Earnings Per Share

45.01

Beta

0.49

EBITDA

68302999552

Book Value

238.047

EPS

45.00196

Company Officers

Name	Title	Age	Year Born
Dr. Sharvil Pankajbhai Patel	MD & Executive Director	45	1979
Dr. Ganesh Narayan Nayak	Executive Director	69	1955
Mr. Punit Patel	President & CEO of America	-	-
Mr. Nitinkumar Dalsukhray Parekh	Chief Financial Officer	-	-
Mr. Arvind Bothra	Head of Investor Relations	-	-
Mr. Dhaval Narendra Soni	Company Secretary & Compliance Officer	-	-
Mr. Vikram Shukla	President of Parenteral Operations	50	1974
Mr. Tushar Dhansukh Shroff	President of Finance	54	1970